Skip to main content

Advertisement

SpringerLink
Log in

Histogenetic Characterization of Giant Cell Tumor of Bone

  • Symposium: Molecular Genetics in Sarcoma
  • Published:
Clinical Orthopaedics and Related Research

Abstract

The unpredictable behavior of giant cell tumor (GCT) parallels its controversial histogenesis. Multinucleated giant cells, stromal cells, and CD68+ monocytes/macrophages are the three elements that interact in GCT. We compared the ability of stromal cells and normal mesenchymal stromal cells to differentiate into osteoblasts. Stromal cells and mesenchymal cells had similar proliferation rates and lifespans. Although stromal cells expressed early osteogenic markers, they were unable to differentiate into osteoblasts but they did express intracellular adhesion molecule-1, a marker of bone-lining cells. They were unable to form clones in a semisolid medium and unable to promote osteoclast differentiation, although they exerted a strong chemotactic effect on osteoclast precursors. Stromal cells may be either immature proliferating osteogenic elements or specialized osteoblast-like cells that fail to show neoplastic features but can induce the differentiation of osteoclast precursors. They might be secondarily induced to proliferate by a paracrine effect induced by monocyte-macrophages and/or giant cells. The increased number of giant cells in GCT may be secondary to an autocrine circuit mediated by the receptor activator of nuclear factor kB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–F
Fig. 2A–E
Fig. 3A–C
Fig. 4A–B
Fig. 5A–C
Fig. 6A–B

Similar content being viewed by others

References

  1. Athanasou NA, Bliss E, Gatter KC, Heryet A, Woods CG, McGee JO. An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol. 1985;147:153–158.

    Article  PubMed  CAS  Google Scholar 

  2. Bauer FC, Urist MR. The reaction of giant cell tumors of bone to transplantation into athmic mice: including observations on osteoinduction in the host bed. Clin Orthop Relat Res. 1981;159:257–264.

    PubMed  Google Scholar 

  3. Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M. Giant-cell tumor of bone with pulmonary metastases: six case reports and a review of the literature. Clin Orthop Relat Res. 1988;237:275–285.

    PubMed  Google Scholar 

  4. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352.

    Article  PubMed  CAS  Google Scholar 

  5. Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (‘dedifferentiated’ primary malignant GCT): report of two cases. Skeletal Radiol. 1997;26:246–255.

    Article  PubMed  CAS  Google Scholar 

  6. Boriani S, Sudanese A, Baldini N, Picci P. Sarcomatous evolution of giant cell tumor. Ital J Orthop Traumatol. 1986;12:203–211.

    Google Scholar 

  7. Cameron JAP, Marsden ATH, Lumpur K. Malignant osteoclastoma. J Bone Joint Surg Br. 1952;34:93–96.

    PubMed  Google Scholar 

  8. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–113.

    PubMed  CAS  Google Scholar 

  9. Campanacci M, Giunti A, Olmi R. Giant-cell tumours of bone. A study of 209 cases with long-term follow-up in 130. Ital J Orthop Traumatol. 1975;1:153–180.

    Google Scholar 

  10. D’Amelio P, Grimaldi A, Pescarmona GP, Tamone C, Roato I, Isaia G. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J. 2004;19:410–412.

    PubMed  Google Scholar 

  11. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cfba1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747–754.

    Article  PubMed  CAS  Google Scholar 

  12. Everts V, Delaissè JM, Korper W, Janses DC, Tighcelaar-Gutter W, Safting P, Beertsen A. The bone lining cell: its role in cleaning Howship’s lacunae and initiating bone formation. J Bone Miner Res. 2002;17:77–90.

    Article  PubMed  CAS  Google Scholar 

  13. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Merli M, Ferrari C, Magagnoli G, Bertoni F, Picci P. Prognostic relevance of C-myc gene expression in giant-cell tumor of bone. J Orthop Res. 1998,16:1–7.

    Article  PubMed  CAS  Google Scholar 

  14. Goldring SR, Roelke MS, Petrison KK, Bhan AK. Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest. 1987;79:483–491.

    Article  PubMed  CAS  Google Scholar 

  15. Granchi D, Amato I, Battistelli L, Avnet S, Capaccioli S, Papucci L, Donnini M, Pellacani A, Brandi ML, Giunti A, Baldini N. In vitro blockade of receptor activator of nuclear factor-kb ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer. 2004;111:829–838.

    Article  PubMed  CAS  Google Scholar 

  16. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 2006;52:499–509.

    PubMed  CAS  Google Scholar 

  17. Harada H, Tagashira S, Fujivara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem. 1999;274:6927–6928.

    Article  Google Scholar 

  18. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15:2–12.

    Article  PubMed  CAS  Google Scholar 

  19. Huang L, Teng XY, Cheng YY, Lee KM, Kumta SM. Expression of preosteoblast markers and Cbfa1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone. 2004;34:393–401.

    Article  PubMed  CAS  Google Scholar 

  20. Huang L, Xu J, Wood JD, Zeng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kB in giant cell tumor of bone. Am J Pathol. 2000;156:761–767.

    PubMed  CAS  Google Scholar 

  21. Huang TS, Green AD, Beattie CW, Das Gupta TK. Monocyte-macrophage lineage of giant cell tumor of bone. Establishment of a multinucleated cell line. Cancer. 1993;71:1751–1760.

    Article  PubMed  CAS  Google Scholar 

  22. Husheem M, Nyman JK, Vääräniemi J, Vaanenen HK, Hentunen TA. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay. Calcif Tissue Int. 2005;76:222–230.

    Article  PubMed  CAS  Google Scholar 

  23. Jaffe JL, Lichtenstein L, Portis RB. Giant cell tumor of bone: its pathologic appearance, grading, supposed variants and treatment. Arch Pathol. 1940;30:993–1031.

    Google Scholar 

  24. Joyner CJ, Quinn JM, Triffitt JT, Owen ME, Athanasou NA. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone Miner. 1992;16:37–48.

    Article  PubMed  CAS  Google Scholar 

  25. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764.

    Article  PubMed  CAS  Google Scholar 

  26. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 2007;8:70–84.

    Article  PubMed  CAS  Google Scholar 

  27. Kusuzaki K, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T, Hirasawa Y. Relationship between binucleated and multinucleated cells in giant cell tumor of bone. Anticancer Res. 2000;20:2463–2468.

    PubMed  CAS  Google Scholar 

  28. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005:36:945–954.

    Article  PubMed  CAS  Google Scholar 

  29. Liao TS, Yurgelun MB, Chang SS, Zhang HZ, Murakami K, Blaine TA, Parisien MV, Kim W, Winchester RJ, Lee FYL. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res. 2005;23:203–209.

    Article  PubMed  CAS  Google Scholar 

  30. Lindeman JHN, Hanemaaijer R, Mulder A, Dijkstra S, Szuhai K, Bromme D, Verheijen JH, Hogendoorn PC. Cathespin K is the principal protease in giant cell tumor of bone. Am J Pathol. 2004;165:593–601.

    PubMed  CAS  Google Scholar 

  31. Mankin HJ, Connor JF, Schiller AL, Perlmutter N, Alho A, McGuire M. Grading of bone tumors by analysis of nuclear DNA content using flow cytometry. J Bone Joint Surg Am. 1985;67:404–413.

    PubMed  CAS  Google Scholar 

  32. Marletta G, Ciapetti G, Satriano C, Perut F, Salerno M, Baldini N. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsilon-caprolactone. Biomaterials. 2007;28:1132–1140.

    Article  PubMed  CAS  Google Scholar 

  33. Mathon AN, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer. 2001;1:203–213.

    Article  PubMed  CAS  Google Scholar 

  34. Miyamoto N, Higuchi Y, Takima M, Ito M, Tsurudome M, Nishio M, Kawano M, Sudo A, Uchida A, Ito Y. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. J Orthop Res. 2000;18:647–654.

    Article  PubMed  CAS  Google Scholar 

  35. Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, Slavin JL, Simmons P, Dickinson I, Powell G, Choong PF, Holloway AJ, Thomas DM. Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol. 2005;167:117–128.

    PubMed  CAS  Google Scholar 

  36. Murata A, Fujita T, Kawahara N, Tsuchiya H, Tomita K. Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci. 2005;10:581–588.

    Article  PubMed  Google Scholar 

  37. Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ, Gregorio-King C, Kirkland MA, Myers DE. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci. 2000;99:133–140.

    Article  PubMed  CAS  Google Scholar 

  38. Nishimura M, Yuasa K, Mori K, Miyamoto N, Ito M, Tsurudome M, Nishio M, Kawano M, Komada H, Uchida A, Ito Y. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact. J Orthop Res. 2005;23:979–987.

    Article  PubMed  CAS  Google Scholar 

  39. O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994;76:1827–1833.

    PubMed  CAS  Google Scholar 

  40. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–322.

    Article  PubMed  CAS  Google Scholar 

  41. Schuffstall RM, Gregory JE. Osteoid formation in giant cell tumours of bone. Am J Pathol. 1953;29:1113–1131.

    Google Scholar 

  42. Scotlandi K, Serra M, Manara C, Maurici D, Benini S, Nini G, Campanacci M, Baldini N. Clinical relevance of Ki-67 expression in bone tumors. Cancer. 1995;75:806–814.

    Article  PubMed  CAS  Google Scholar 

  43. Tanaka Y, Maruo A, Kujii K, Nomi M, Nakamura T, Eto S, Minami Y. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J Bone Miner Res. 2000;15:1912–1923.

    Article  PubMed  CAS  Google Scholar 

  44. Tanaka Y, Mine S, Hanagiri T, Hiraga T, Morimoto I, Figdor CG, van Kooyk Y, Ozawa H, Nakamura T, Yasumoto K, Eto S. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Cancer Res. 1998;58:4138–4145.

    PubMed  CAS  Google Scholar 

  45. Tanaka Y, Morimoto I, Nakano Y, Okada Y, Hirota S, Nomura S, Nakamura T, Eto S. Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J Bone Miner Res. 1995;10:1462–1469.

    Article  PubMed  CAS  Google Scholar 

  46. Wulling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. J Cancer Res Clin Oncol. 2001;34:983–993.

    Google Scholar 

  47. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol. 2001;16:297–307.

    PubMed  CAS  Google Scholar 

  48. Zheng MH, Siu P, Papadimitriou JM, Wood DJ, Murch AR. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone. Pathology. 1999;31:373–378.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Pathophysiology, Istituto Ortopedico Rizzoli, 40136, Bologna, Italy

    Manuela Salerno MSc, Sofia Avnet PhD, Armando Giunti MD & Nicola Baldini MD

  2. Service of Pathology, Istituto Ortopedico Rizzoli, 40136, Bologna, Italy

    Marco Alberghini MD

  3. Department of Orthopaedic Surgery, University of Bologna Medical School, Bologna, Italy

    Armando Giunti MD & Nicola Baldini MD

Authors
  1. Manuela Salerno MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sofia Avnet PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Alberghini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Armando Giunti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicola Baldini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Baldini MD.

Additional information

One or more of the authors (NB) has received funding from the Italian Association for Cancer Research.

Each author certifies that his or her institution has approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.

About this article

Cite this article

Salerno, M., Avnet, S., Alberghini, M. et al. Histogenetic Characterization of Giant Cell Tumor of Bone. Clin Orthop Relat Res 466, 2081–2091 (2008). https://doi.org/10.1007/s11999-008-0327-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-008-0327-z

Keywords

Search

Navigation